Lu AF82422 is really a mAb proven as Risk-free and well tolerated in a very phase I demo in balanced subjects and clients with PD (NCT03611569). A phase II study investigating the safety and efficacy in individuals https://ksnr.org.in/multiple-system-atrophy/